Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of gastric and duodenal illnesses
3.2.1.2 Increasing need for effective anti-microbial treatments
3.2.1.3 Advancements in laboratory serological assay
3.2.1.4 Growing demand for point-of-care testing devices
3.2.2 Industry pitfalls & challenges
3.2.2.1 Strict regulatory regulations and the low detection rate of H. pylori infection
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technological landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
3.9 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Serologic test
5.3 Urea breath test
5.4 Stool/fecal antigen test
Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Laboratory based test
6.3 Point of care (POC) test
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Diagnostic laboratories
7.5 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott
9.2 Biohit Oyj
9.3 Bio-Rad Laboratories, Inc.
9.4 Cardinal Health
9.5 certest Biotech srl
9.6 Fisher Scientific
9.7 Gulf Coast Scientific
9.8 Meridian Bioscience Inc.
9.9 Quidel Corporation
9.10 Tri-Med
